FI962685A0 - 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi - Google Patents

2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi

Info

Publication number
FI962685A0
FI962685A0 FI962685A FI962685A FI962685A0 FI 962685 A0 FI962685 A0 FI 962685A0 FI 962685 A FI962685 A FI 962685A FI 962685 A FI962685 A FI 962685A FI 962685 A0 FI962685 A0 FI 962685A0
Authority
FI
Finland
Prior art keywords
diaryl
osteoporosis
medicament
prevention
manufacture
Prior art date
Application number
FI962685A
Other languages
English (en)
Swedish (sv)
Other versions
FI962685A (fi
Inventor
Virender M Labroo
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of FI962685A0 publication Critical patent/FI962685A0/fi
Publication of FI962685A publication Critical patent/FI962685A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI962685A 1993-12-30 1996-06-28 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi FI962685A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/175,899 US5389646A (en) 1993-12-30 1993-12-30 Methods for treatment and prevention of bone loss using 2,3-benzopyrans
PCT/US1994/014568 WO1995017892A1 (en) 1993-12-30 1994-12-14 Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis

Publications (2)

Publication Number Publication Date
FI962685A0 true FI962685A0 (fi) 1996-06-28
FI962685A FI962685A (fi) 1996-08-28

Family

ID=22642125

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962685A FI962685A (fi) 1993-12-30 1996-06-28 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi

Country Status (11)

Country Link
US (1) US5389646A (fi)
KR (1) KR100213963B1 (fi)
CN (1) CN1142767A (fi)
AU (1) AU701411B2 (fi)
CA (1) CA2180178C (fi)
CZ (1) CZ192396A3 (fi)
FI (1) FI962685A (fi)
HU (1) HUT75705A (fi)
NO (1) NO962752L (fi)
RU (1) RU2166316C2 (fi)
WO (1) WO1995017892A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US5637598A (en) * 1994-11-18 1997-06-10 Eli Lilly And Company Methods of inhibiting bone loss
BR9711805A (pt) * 1996-06-20 2002-01-15 Regents The Univesity Of Texas Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8080675B2 (en) * 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
NZ553834A (en) 2004-09-21 2010-03-26 Novogen Res Pty Ltd 7-hydroxy-3,4-diphenyl-chroman and chromene derivatives
EA022551B1 (ru) 2010-06-10 2016-01-29 Серагон Фармасьютикалс, Инк. Модуляторы рецепторов эстрогена и их применение
ES2773732T3 (es) 2010-11-01 2020-07-14 Mei Pharma Inc Composiciones de isoflavonoides y procedimientos para el tratamiento del cáncer
CA2857057A1 (en) 2011-12-14 2013-06-20 Seragon Pharmaceuticals, Inc. Fluorinated estrogen receptor modulators and uses thereof
DK3253208T3 (da) 2015-02-02 2021-06-07 Mei Pharma Inc Kombinationsterapier til anvendelse i behandlingen af brystcancer
CN104926776B (zh) * 2015-07-06 2018-05-25 江南大学 4-苯甲酰亚甲基黄烷类衍生物的绿色合成方法
SG11201803119XA (en) 2015-10-27 2018-05-30 Sun Pharma Advanced Res Co Ltd Novel heterocyclic antiestrogens
PE20221588A1 (es) 2019-07-22 2022-10-10 Sun Pharma Advanced Res Co Ltd Degradador selectivo del receptor de estrogeno

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US4210644A (en) * 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US4489056A (en) * 1982-06-30 1984-12-18 Merck & Co., Inc. Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
JPS60132976A (ja) * 1983-12-21 1985-07-16 Takeda Chem Ind Ltd 新規３−フエニル−４ｈ−１−ベンゾピラン−４−オン誘導体
US4644012A (en) * 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
US5254568A (en) * 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
JP3502403B2 (ja) * 1991-12-16 2004-03-02 アベンティス ファーマ株式会社 骨吸収抑制剤
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
RU2166316C2 (ru) 2001-05-10
KR100213963B1 (en) 1999-08-02
HUT75705A (en) 1997-05-28
US5389646A (en) 1995-02-14
CZ192396A3 (en) 1997-03-12
NO962752D0 (no) 1996-06-28
CA2180178C (en) 2001-03-20
AU701411B2 (en) 1999-01-28
HU9601786D0 (en) 1996-09-30
NO962752L (no) 1996-08-29
WO1995017892A1 (en) 1995-07-06
AU1403995A (en) 1995-07-17
CN1142767A (zh) 1997-02-12
FI962685A (fi) 1996-08-28
CA2180178A1 (en) 1995-07-06

Similar Documents

Publication Publication Date Title
HK1011926A1 (en) The use of bisphosphonates in bone surgery
IL127714A0 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders
ATA126393A (de) Chirurgisches handstück
GB9415125D0 (en) Surgical product and its use
GB8821360D0 (en) Orthopaedic brace
GB2232085B (en) Bolt for orthopaedic surgical use
FI962685A0 (fi) 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
EE03878B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
GB9213008D0 (en) Knee surgery
KR960702749A (ko) 심장혈관 질환의 치료를 위한 천연물 및 이와 관련된 합성 화합물의 사용(Use of Natural Products and Related Synthetic Compounds for the Treatment of Cardiovascular Disease)
EP0744176A3 (en) Methods for inhibiting bone loss
GB9303200D0 (en) Orthopaedic casting bandage
EP0263552A3 (en) Composite material for medical or paramedical, particularly orthopaedic use and method for manufacturing it
HUP9802736A3 (en) Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
AU2143892A (en) Use of formoterol for treatment of tissue injury
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
FI953622A (fi) Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon
ZA944187B (en) Ipsapirone medicament formulation
AU1176295A (en) Orthopedic casts
IL123422A0 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivatives for the manufacture of a medicament for the prophylaxis or the treatment of atherosclerosis
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis